Republican Congressman indicted for insider trading


Republican Congressman Collins and His Fearless LeaderThe Nation

❝ Five GOP House members bought shares of an Australian biotechnology company in January 2017 that’s at the center of an insider trading indictment of New York Republican Chris Collins, congressional financial disclosures show.

Collins, who represents a district in western New York, is the only lawmaker accused by prosecutors of wrongdoing — stemming from his role on Innate Immunotherapeutics Ltd.’s board, not his position in the House.

But the allegations against him, along with the other lawmakers’ holdings, highlight how members of Congress face few restrictions on their investments, creating the potential for conflicts of interest, or the appearance of a conflict…

❝ Collins, one of the biotechnology company’s largest shareholders who served on the board and had access to information that wasn’t public, is accused of tipping off his son about the trial results for a drug to treat a form of multiple sclerosis, according to federal prosecutors in New York. His son Cameron Collins then passed along the information to others. The son and others who received the tip sold more than 1.78 million shares in the days before the trial results were announced, avoiding losses of $768,000…

Trump provides apt leadership for the majority of creeps in government. As Mark Twain said, “It could probably be shown by facts and figures that there is no distinctly native American criminal class except Congress”.

Trump wants taxpayers to payoff corporate farmers screwed by his Trade War

❝ President Donald Trump set off a wave of outrage…among Republican lawmakers, who accused the president of authorizing a “bailout” and “welfare” for Americans caught in the crosshairs of his own tariffs.

“It’s awful. American farmers want markets, not handouts. This is what we feared all along—that this would just turn into more aid programs,” Sen. Jeff Flake (R-AZ) told The Daily Beast.

❝ Reactions—nearly all of them negative—poured in from Capitol Hill after the Department of Agriculture announced that it would authorize $12 billion in “emergency” subsidies to farmers whose businesses have been hurt by the president’s trade policies, which have sparked retaliatory tariffs from China, Canada, Mexico, and the European Union…

❝ “Our farmers have been in non-stop saying they want trade not aid. And now they’re being put on welfare. So the tariff policies that have been put in place by the administration are now causing them to invoke a welfare policy for our farmers, which I’m sure is not what they wish,” Sen. Bob Corker (R-TN), who has proposed legislation requiring congressional approval of some tariffs, told reporters…

“The administration creates a problem for farmers, and now they need to put them on welfare. I think that’s kind of a misplaced policy,” Corker added.

RTFA for even more. When I first heard this silly-ass proposal my hope was that a few Congressional Republicans remained who weren’t full-time Trump pimps – and would raise a fuss. Here we go!

Republicans shut down important healthcare resource — Big Pharma applauds

❝ America’s federal database of medical treatment guidelines—a resource for doctors, hospitals, and patients for more than two decades—will be dead on Tuesday (July 17). The National Guideline Clearinghouse website at Guidelines.gov was shut down by the Agency for Healthcare Research and Quality, it said, because “Federal funding through AHRQ will no longer be available to support the NGC.”

❝ Rep. Hal Rogers (R-Ky.), chair of the House Appropriations Committee until the beginning of last year, had targeted the agency for elimination even after doctors warned him not to kill Guidelines.gov. As TYT reported on Sunday, Rogers doubled the number of health-industry companies in which he invested last year…The White House also pitched killing the research agency…

❝ …Big healthcare companies have billions of dollars at stake in which guidelines consumers use. An estimated 200,000 visitors turned to Guidelines.gov each month. For decades, the federal guidelines have had something of a monopoly. As of Tuesday, that will no longer be the case.

NO lobby forks over more dollar$ to members of Congress than Big Pharma. Keeping the American drugs industry at a level of profits exceeding their take in any other country is worth every member of Congress they can buy.